MC

Mark Chasin

ES Euro-Celtique S.A.: 63 patents #1 of 215Top 1%
PP Purdue Pharma: 14 patents #29 of 189Top 20%
MIT: 1 patents #4,386 of 9,367Top 50%
NP Nova Pharmaceutical: 1 patents #10 of 26Top 40%
📍 Sparta, NJ: #1 of 375 inventorsTop 1%
🗺 New Jersey: #342 of 69,400 inventorsTop 1%
Overall (All Time): #22,256 of 4,157,543Top 1%
81
Patents All Time

Issued Patents All Time

Showing 1–25 of 81 patents

Patent #TitleCo-InventorsDate
10092519 Pharmaceutical products Benjamin Oshlack, Glenn Van Buskirk, Hua-Pin Huang, Vijay Vashi 2018-10-09
9149436 Pharmaceutical product comprising a sequestered agent Benjamin Oshlack, Glenn Van Buskirk, Hua-Pin Huang, Vijay Vashi 2015-10-06
7510727 Melt-extrusion multiparticulates Benjamin Oshlack, Hua-Pin Huang 2009-03-31
7316821 Stabilized controlled release substrate having a coating derived from an aqueous dispersion of hydrophobic polymer Benjamin Oshlack, Frank Pedi, Jr. 2008-01-08
7270831 Orally administrable opioid formulations having extended duration of effect Benjamin Oshlack 2007-09-18
7070806 Controlled release formulations coated with aqueous dispersions of acrylic polymers Benjamin Oshlack, Frank Pedi, Jr. 2006-07-04
6921541 Formulations and methods for providing prolonged local anesthesia Paul Goldenheim, Richard Sackler, Joseph Tigner, Ronald M. Burch 2005-07-26
6905709 Stabilized controlled release substrate having a coating derived from an aqueous dispersion of hydrophobic polymer Benjamin Oshlack, Frank Pedi, Jr. 2005-06-14
6743442 Melt-extruded orally administrable opioid formulations Benjamin Oshlack, Hua-Pin Huang, David Sackler 2004-06-01
6706281 Melt-extrusion multiparticulates Benjamin Oshlack, Hua-Pin Huang 2004-03-16
6699908 Methods for providing safe local anesthesia Richard Sackler, Paul Goldenheim, Ronald M. Burch, Robert F. Reder, Joseph Tigner 2004-03-02
6645527 Stabilized sustained release tramadol formulations Benjamin Oshlack, Hua-Pin Huang, Paul Goldenheim 2003-11-11
6572885 Orally administrable opioid formulations having extended duration of effect Benjamin Oshlack 2003-06-03
6534081 Prolonged anesthesia in joints and body spaces Paul Goldenheim, Donna Donigi-Gale, Richard Sackler, Peter Lacouture 2003-03-18
6524607 Formulations and methods for providing prolonged local anesthesia Paul Goldenheim, Richard Sackler, Ronald M. Burch, Joseph Tigner 2003-02-25
6521259 Formulations and methods for providing prolonged local anesthesia Richard Sackler, Ronald M. Burch, Paul Goldenheim, Joseph Tigner 2003-02-18
6514516 Formulations and methods for providing prolonged local anesthesia Richard Sackler, Ronald M. Burch, Paul Goldenheim, Joseph Tigner 2003-02-04
6451335 Formulations and methods for providing prolonged local anesthesia Paul Goldenheim, Donna Donigi-Gale, Kevin Burton, Mohammed Shameem, Amol Ketkar +1 more 2002-09-17
6440979 Aryl isoguanines David Cavalla, Peter Hofer 2002-08-27
6413975 Purine derivatives having phosphodiesterase iv inhibition activity David Cavalla, Peter Hofer, Andre Gehrig, Peter Wintergerst 2002-07-02
6387404 Immediate release tablet cores of insoluble drugs having sustained-release coating Benjamin Oshlack 2002-05-14
6372770 Benzoxazoles David Cavalla, Peter Hofer, Lloyd J. Dolby 2002-04-16
6365606 6,5-fused aromatic ring systems having enhanced phosphodiesterase IV inhibitory activity David Cavalla, Peter Hofer, Andre Gehrig, Peter Wintergerst 2002-04-02
6335033 Melt-extrusion multiparticulates Benjamin Oshlack, Hua-Pin Huang 2002-01-01
6319928 Purine derivatives having phosphodiesterase IV inhibition activity David Cavalla, Peter Hofer, Peter Wintergerst, Andre Gehrig 2001-11-20